Volume 22, Number 3Case ReviewFrom Radical to Partial Nephrectomy in the Setting of Solitary Functioning Kidney: Neoadjuvant Treatment of Renal Cell CarcinomaDavid D WatsonNicole G FarhaK James KallailShaker DakhilA J FarhaImmunotherapy has revolutionized the treatment of metastatic renal cell carcinoma (RCC). This case evaluates the use of neoadjuvant immunotherapy for localized RCC in a patient with solitary functioning kidney. A retrospective chart review was conducted between September 2019 and January 2020 on a single patient. Before treatment, the tumor was 7 cm × 8 cm × 8.5 cm. The patient trialed nivolumab + ipilimumab then cabozantinib. The tumor shrunk to 6.3 cm × 5.5 cm and was removed via partial nephrectomy. This case demonstrates the efficacy of immunotherapy in neoadjuvant treatment of RCC. Expansion of guidelines could allow for patients with RCC to undergo partial nephrectomy. [Rev Urol. 2020;22(3):126-129] © 2020 MedReviews®, LLCRenal cell carcinomaImmunotherapyNeoadjuvant immunotherapySolitary kidney
Volume 22, Number 4CorrigendaAuthor’s Name Correction for “From Radical to Partial Nephrectomy in the Setting of Solitary Functioning Kidney: Neoadjuvant Treatment of Renal Cell Carcinoma,” Rev Urol. 2020;22(3):126–129David D WatsonNicole G FarhaK James KallailShaker DakhilA J Farha[Rev Urol. 2020;22(4):186] © 2021 MedReviews®, LLC